PGEN:NASDAQ
Precigen Inc
$7.10
arrow_downward
-0.56%(-0.040) 1D
$7.07
arrow_downward
-0.42% (-0.030)bedtimeAfter hours
Closed: Sep 4, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PGEN...
Open
$7.12
High
$7.27
Low
$7.08
Mkt. cap
2.54B
Avg. vol.
5.50M
Volume
2.19M
52-wk high
$7.72
52-wk low
$2.99
EPS
-$1.10
Beta
1.02
Shares outstanding
358.04M
No. of employees
160
Open
$7.12
High
$7.27
Low
$7.08
Mkt. cap
2.54B
Avg. vol.
5.50M
Volume
2.19M
52-wk high
$7.72
52-wk low
$2.99
EPS
-$1.10
Beta
1.02
Shares outstanding
358.04M
No. of employees
160
News stories
From web sources and news partners
Zacks
·
2 days ago
Krystal Stock Gains 13.4% in a Month: What Is Driving the Rally?
Profile
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
About Precigen Inc
CEOHelen Sabzevari
Employees160
FoundedMay 21, 1998
Headquarters-
SectorBiotechnology
Websiteprecigen.com